What does GRED mean in ONCOLOGY
Genentech Research and Early Development (gRED) is a division of Genentech, a biotechnology company that focuses on medical research and drug development. gRed works to bring the most innovative breakthrough medicines to those who need them.
gRED meaning in Oncology in Medical
gRED mostly used in an acronym Oncology in Category Medical that means Genentech Research and Early Development
Shorthand: gRED,
Full Form: Genentech Research and Early Development
For more information of "Genentech Research and Early Development", see the section below.
Essential Questions and Answers on Genentech Research and Early Development in "MEDICAL»ONCOLOGY"
What does gRED stand for?
gRED stands for Genentech Research and Early Development.
What types of services does gRED provide?
gRED works to discover, develop, and deliver innovative breakthrough medicines to those who need them.
Who is eligible for services offered by gRED?
People with diseases or conditions that may be treatable with the medications developed by gRed may be eligible to receive these treatments.
How will people know if they are eligible for treatments from gRED?
Patients must consult their healthcare provider in order to determine whether they are eligible for treatments from gRED.
Where is gRed located?
Genentech Research and Early Development is located in South San Francisco, California.
Final Words:
Genentech Research and Early Development (gRed) works towards providing innovative breakthrough medicines to those who need them in South San Francisco, California. To find out more about eligibility criteria and other services from gRed, patients should consult their healthcare provider.